Novelcare

The interesting design decision in Novelcare is who initiates. Most trial-matching products put the patient in the driver's seat, which means the patient has to know trials exist, go looking, and self-assess eligibility — a process that mostly fails for anyone who is already unwell. Novelcare reverses it: the platform surfaces local, medically relevant options to the physician, the physician flags the patient, and the platform sends the study information to the patient. That is a much shorter path, and it keeps the doctor's judgment in the loop where it belongs clinically. The second thing worth noting is what Novelcare does not ask you to change. The homepage states that you keep your clinical workflow and that study information is sent automatically to patients you identify as relevant. For a busy practice, the deciding factor on any add-on tool is usually not capability but disruption, and this positioning attacks that directly. The commercial framing is straightforward and, per the vendor, favorable: the service is described as free for most practices and there is a stated revenue opportunity through chart review for some studies — the homepage claims "positive ROI on day one." Treat that as the vendor's framing rather than a guarantee, and verify the specifics for your own studies. No pricing page was reachable in this research pass, so pricing beyond that vendor statement is not something we can restate. The trust posture is more developed than most. The site dedicates a page to Trust and HIPAA & Security and leads the security section with "HIPAA-compliance is just the starting line." The CEO letter names alignment, thoughtful design, clear boundaries, and shared purpose, and says the model — technology, operations and contracts — was built to protect that trust. For a tool that touches patient data and triggers patient communication, that is the section I would read first as a buyer, and Novelcare is at least explicit about where its boundaries are rather than burying them. Where it fits: primary care physicians who want to offer trials without extra admin, specialists with hard-to-treat patients who have run out of standard options, trial sites that want physician-led matching, and practices that want a chart review revenue line. The patient stories on the homepage — depression and weight-related conditions — show the intended emotional context: patients who have cycled through options. Where it does not fit: practices that need a full EHR replacement or deep native EHR integration (Novelcare is an add-on to how you already work, not a system of record), patients who want to find trials themselves without going through a provider (Novelcare is clinician-initiated by design), healthcare systems that want extensive API-level integration, and anyone practicing in an area with little trial activity. That last one is the real ceiling on this product — coverage is geographic, and no feature set can fix an empty trial map. Practical